Literature DB >> 23071347

The impact of acquisition time on image quality in whole-body 18F-FDG PET/CT for cancer staging.

Daniel Hausmann1, Dietmar J Dinter, Maliha Sadick, Joachim Brade, Stefan O Schoenberg, Karen Büsing.   

Abstract

UNLABELLED: Our objective was to evaluate the impact of acquisition time on image quality, lesion detection rate, standardized uptake values, and lesion volume for (18)F-FDG PET in cancer patients.
METHODS: Over 7 mo, 33 cancer patients were included in this study. In these patients, 63 lesions were independently evaluated by 2 nuclear medicine specialists (experienced and beginner). Two consecutive whole-body (18)F-FDG PET/CT scans using a 3-min and 1.5-min acquisition time per bed position were obtained for each patient. Lesions were visually identified, and their locations were compared. The lesion volumes and standardized uptake values of the primary tumor, lymph nodes, and metastases were determined and compared. Image quality was scored using a 5-range Likert-type scale. For all parameters, interobserver agreement was assessed.
RESULTS: All relevant lesions could be identified at both acquisition times. Image quality was slightly adversely affected by an acquisition time of 1.5 min but was excellent or good in 85% of the scans. In a patient with increased blood sugar levels, the image quality was rated moderate at 3 min and poor at 1.5 min. The quality of lesion visualization was excellent regardless of the acquisition time. Lesion volume and maximum standardized uptake value on PET images showed an excellent correlation between the 2 acquisition times (Pearson correlation coefficient, 0.99 and 0.97, respectively). Interobserver agreement was excellent (κ > 0.83).
CONCLUSION: Although image quality is slightly poorer, reducing the acquisition time to 1.5 min per bed position seems to be clinically feasible without decreasing the lesion detection rate even for less experienced observers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23071347     DOI: 10.2967/jnmt.112.103291

Source DB:  PubMed          Journal:  J Nucl Med Technol        ISSN: 0091-4916


  5 in total

Review 1.  Influences on PET Quantification and Interpretation.

Authors:  Julian M M Rogasch; Frank Hofheinz; Lutz van Heek; Conrad-Amadeus Voltin; Ronald Boellaard; Carsten Kobe
Journal:  Diagnostics (Basel)       Date:  2022-02-10

2.  Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer.

Authors:  Hui Tan; Xiuli Sui; Hongyan Yin; Haojun Yu; Yusen Gu; Shuguang Chen; Pengcheng Hu; Wujian Mao; Hongcheng Shi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-11-27       Impact factor: 9.236

Review 3.  Dosage optimization in positron emission tomography: state-of-the-art methods and future prospects.

Authors:  Nicolas A Karakatsanis; Eleni Fokou; Charalampos Tsoumpas
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-10-12

4.  For avid glucose tumors, the SUV peak is the most reliable parameter for [(18)F]FDG-PET/CT quantification, regardless of acquisition time.

Authors:  Avigaëlle Sher; Franck Lacoeuille; Pacôme Fosse; Laurent Vervueren; Aurélie Cahouet-Vannier; Djamel Dabli; Francis Bouchet; Olivier Couturier
Journal:  EJNMMI Res       Date:  2016-03-05       Impact factor: 3.138

5.  Optimization of PET protocol and interrater reliability of 18F-PSMA-11 imaging of prostate cancer.

Authors:  Sarah Piron; Kathia De Man; Vanessa Schelfhout; Nick Van Laeken; Ken Kersemans; Eric Achten; Filip De Vos; Piet Ost
Journal:  EJNMMI Res       Date:  2020-02-24       Impact factor: 3.138

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.